# FMC Corp: Form 10-Q for the period ended Sep 30, 2011

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2011-11-02
- Accepted by EDGAR: Nov 2, 2011, 17:47 ET
- Period: 2011-09-30
- Accession: 0000037785-11-000033
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000003778511000033/fmc930201110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000003778511000033/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2011-07-01 to 2011-09-30 | $862.1m | us-gaap:Revenues |
| Revenue | 9 months, 2011-01-01 to 2011-09-30 | $2.47bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2011-07-01 to 2011-09-30 | $574.7m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2011-01-01 to 2011-09-30 | $1.59bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2011-07-01 to 2011-09-30 | $287.4m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2011-01-01 to 2011-09-30 | $874.3m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2011-07-01 to 2011-09-30 | $110.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2011-01-01 to 2011-09-30 | $325.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2011-07-01 to 2011-09-30 | $135.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2011-01-01 to 2011-09-30 | $446.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2011-07-01 to 2011-09-30 | $29.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2011-01-01 to 2011-09-30 | $96.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2011-07-01 to 2011-09-30 | $86.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2011-01-01 to 2011-09-30 | $288.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2011-07-01 to 2011-09-30 | $1.21 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2011-01-01 to 2011-09-30 | $4.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2011-07-01 to 2011-09-30 | $1.22 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2011-01-01 to 2011-09-30 | $4.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2011-07-01 to 2011-09-30 | 71,534,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2011-01-01 to 2011-09-30 | 71,927,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2011-01-01 to 2011-09-30 | $327.8m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2011-01-01 to 2011-09-30 | $119.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2011-01-01 to 2011-09-30 | $30.6m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2011-01-01 to 2011-09-30 | $114.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2011-09-30 | $109.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-09-30 | $1.69bn | us-gaap:AssetsCurrent |
| Total assets | at 2011-09-30 | $3.39bn | us-gaap:Assets |
| Current liabilities | at 2011-09-30 | $909.5m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2011-09-30 | $493.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2011-09-30 | $47.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2011-09-30 | $1.32bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2011-09-30 | 70,423,009 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 71,818 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, “expects”, “should”, “could”, “may”, “will continue to”, “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information. The forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, these statements. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2010 (the “2010 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We further caution that the list of risk factors in Item 1A in Part I of the 2010 10-K may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2010 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Application of Critical Accounting Policies” section in our 2010 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Environmental obligations and related recoveries
- Impairment and valuation of long-lived assets
- Pensions and other postretirement benefits
- Income taxes

We did not adopt any changes in the current period that had a material effect on these critical accounting policies nor did we make any changes to our accounting policies that would have changed these critical accounting policies.

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to our condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in three distinct business segments: Agricultural Products, Specialty Chemicals and Industrial Chemicals. Our Agricultural Products segment develops, markets and sells all three major classes of crop protection chemicals - insecticides, herbicides, and fungicides - with particular strength in insecticides and herbicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as pest control in non-agricultural markets. Specialty Chemicals consists of our BioPolymer and lithium businesses and focuses on food ingredients that are used to enhance texture, structure and physical stability, pharmaceutical additives for binding, encapsulation and disintegrant applications, ultrapure biopolymers for medical devices and lithium for energy storage, specialty polymers and pharmaceutical synthesis. Our Industrial Chemicals segment manufactures a wide range of inorganic materials, including soda ash, hydrogen peroxide, specialty peroxygens, zeolites and silicates. Through the end of 2010, our Industrial Chemicals segment held a niche position in phosphorous chemicals products.

### 2011 Highlights

Our businesses continue to experience positive results from the increase in global economic activity resulting in higher volumes

and higher pricing. Results for the three and nine months ended September 30, 2011, reflect increases in both consolidated revenues and earnings driven by solid performance in all three of our operating segments.

The following are the more significant developments in our businesses during the three months ended September 30, 2011:

- Revenue of $862 million for the three months ended September 30, 2011 increased $117 million or 16 percent versus the last year when excluding the approximate $28 million impact of revenues from the exited phosphate and sulfur derivatives businesses in Spain during 2010. Revenue increased in all businesses and in all regions. A more detailed review of revenues by segment are discussed further on under the section titled "Results of Operations". On a regional basis - adjusted to exclude exited businesses discussed above - sales in Europe, Middle East and Africa increased 16 percent, sales in Asia were up 23 percent, sales in Latin America grew 26 percent and sales in North America were up 5 percent.
- Our gross margin of $287 million increased by $33 million or approximately 13 percent versus last year's third quarter. Gross margin percent of 33 percent equaled that of last year, as higher selling prices offset higher costs.
- Selling, general and administrative expenses, excluding non-operating pension and postretirement charges, of $107 million increased approximately $11 million or 12 percent, largely due to increased spending on targeted growth initiatives in our agricultural products business and to a lesser extent foreign exchange.
- Adjusted Earnings after-tax from continuing operations attributable to FMC stockholders of approximately $99 million increased approximately $13 million or 15 percent primarily due to higher operating results in all three of our segments. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".
- During the quarter, we experienced an increase in restructuring and other charges (income) of $10 million. The majority of the increase in the restructuring charges is associated with the phase out of the Sodium Percarbonate plant assets in La Zaida, Spain.
- We also completed the following Vision 2015 growth initiatives:
- In July 2011, we established Ruralco Soluciones, a joint venture in Argentina to directly access the country's large and growing agrochemicals market.
- In September 2011, we formed Natronx Technologies in partnership with Church & Dwight and TATA Chemicals to manufacture and market sodium-based, dry sorbents for air pollution control in electric utility and industrial boiler operations.
- In October 2011, we completed the acquisition of the persulfates business of RheinPerChemie to accelerate our shift to high-margin specialty peroxygens.
- Additionally, in October 2011, we announced an agreement to acquire BioGroup, a leading natural colors and health ingredients producer to broaden our food ingredients portfolio.

### RESULTS OF OPERATIONS

### Overview

The following presents a reconciliation of our segment operating profit to net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).

*SEGMENT RESULTS RECONCILIATION*

*(in Millions)*

| 2011 Revenue | Three Months Ended September 30, | 2010 | Nine Months Ended September 30, 2011 | 2010 |
| --- | ---: | ---: | ---: | ---: |
| Agricultural Products | $382.1 | $308.9 | $1,055.3 | $907.3 |
| Specialty Chemicals | 217.9 | 202.2 | 656.5 | 619.4 |
| Industrial Chemicals | 264.0 | 262.4 | 761.3 | 781.7 |
| Eliminations | (1.9) | (1.0) | (3.8) | (2.6) |
| Total | $862.1 | $772.5 | $2,469.3 | $2,305.8 |
| **Income (loss) from continuing operations before income taxes** |  |  |  |  |
| Agricultural Products | $80.9 | $75.1 | $275.7 | $247.5 |
| Specialty Chemicals | 47.6 | 47.1 | 148.5 | 139.0 |
| Industrial Chemicals | 36.0 | 30.0 | 112.5 | 94.3 |
| Eliminations | — | 0.1 | — | 0.2 |
| **Segment operating profit** | $164.5 | $152.3 | $536.7 | $481.0 |
| Corporate | (12.8) | (15.9) | (45.2) | (42.9) |
| Other income (expense), net | (2.9) | (3.5) | (15.1) | (5.6) |
| Operating profit before the items listed below (1) | 148.8 | 132.9 | 476.4 | 432.5 |
| Interest expense, net | (9.1) | (9.6) | (29.5) | (29.0) |
| Corporate special income (charges): |  |  |  |  |
| Restructuring and other (charges) income | (13.4) | (3.7) | (27.2) | (35.7) |
| Non-operating pension and postretirement charges (2) | (3.4) | (4.1) | (12.4) | (9.7) |
| Provision for income taxes | (29.8) | (32.3) | (96.1) | (106.8) |
| Discontinued operations, net of income taxes | (6.3) | (0.3) | (23.2) | (25.3) |
| **Net income attributable to FMC stockholders** | $86.8 | $82.9 | $288.0 | $226.0 |

(1) Results for all segments including corporate expense and other income (expense) are net of noncontrolling interests of $4.1 million and $12.5 million in the three and nine months ended September 30, 2011, respectively and $3.0 million and $9.2 million for the three and nine months ended September 30, 2010, respectively. The majority of these noncontrolling interests pertain to our Industrial Chemicals segment.

(2) Beginning in 2011, we reclassified for all periods presented non-operating pension and postretirement charges to its own line item within the above table. Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs were previously included within Other income (expense), net in the above table and are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in our operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees.

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows.

Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income attributable to FMC stockholders”. We believe that this measure provides useful information about our operating results to investors and securities analysts. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges and certain tax adjustments from operating results allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.

*ADJUSTED EARNINGS RECONCILIATION*

*(in Millions)*

| 2011 | Three Months Ended September 30, | 2010 | Nine Months Ended September 30, 2011 | 2010 |
| --- | ---: | ---: | ---: | ---: |
| **Net income attributable to FMC stockholders (GAAP)** | $86.8 | $82.9 | $288.0 | $226.0 |
| Corporate special charges (income), pre-tax | 16.8 | 7.8 | 39.6 | 45.4 |
| Income tax expense (benefit) on Corporate special charges (income) | (5.5) | (2.7) | (13.2) | (15.7) |
| Corporate special charges (income), net of income taxes | 11.3 | 5.1 | 26.4 | 29.7 |
| Discontinued operations, net of income taxes | 6.3 | 0.3 | 23.2 | 25.3 |
| Tax adjustments | (5.2) | (2.3) | (20.3) | 0.7 |
| **Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)** | $99.2 | $86.0 | $317.3 | $281.7 |

### Three months ended September 30, 2011 compared to three months ended September 30, 2010

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, amortization of inventory step-up from business acquisitions and other related inventory adjustments, and other income and expense items.

Information about how some of these items relate to our businesses at the segment level is discussed in Note 19 of our condensed consolidated financial statements filed in this Form 10-Q and in Note 19 of our 2010 consolidated financial statements in our 2010 10-K.

### Agricultural Products

*(in Millions)*

| 2011 | Three Months Ended September 30, | 2010 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $382.1 | $308.9 | $73.2 | 24% |
| Operating Profit | 80.9 | 75.1 | 5.8 | 8 |

Revenue of $382.1 million increased approximately 24 percent versus the prior year quarter as sales gains were achieved in all regions. Sales in North America improved nine percent to $49.3 million reflecting higher insecticide volumes. Latin America revenue of $227.3 million increased 31 percent driven by favorable market conditions, particularly in Brazil, driven by key crops such as sugarcane, cotton and soybeans. Revenue in Asia of $64.7 million increased 18 percent as a result of newly-launched products, market access initiatives and favorable market conditions in most key countries including, India, Pakistan, China and Thailand. Sales in Europe, Middle East and Africa (EMEA) of $40.8 million increased 16 percent due to strong herbicide volumes in Europe.

Agricultural Products' operating profit of $80.9 million increased approximately 8 percent compared to the year-ago quarter, reflecting the sales growth partially offset by higher raw material costs, less favorable product and geographic mix and a 19% or $9 million increase in selling, general and administrative costs mainly for focused growth initiatives. In addition, segment earnings were unfavorably impacted by the rapid devaluation of the Brazilian Real at the very end of the quarter.

### Specialty Chemicals

*(in Millions)*

| 2011 | Three Months Ended September 30, | 2010 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $217.9 | $202.2 | $15.7 | 8% |
| Operating Profit | 47.6 | 47.1 | 0.5 | 1 |

Revenue in Specialty Chemicals was $217.9 million, an increase of approximately eight percent versus the prior-year quarter. The increase was driven primarily by higher selling prices across the segment and volume growth in pharmaceutical excipients and lithium specialties.

BioPolymer revenue of $164.5 million increased approximately eight percent from the prior-year quarter. This increase was due to higher volumes which increased revenue by one percent, favorable pricing which impacted sales by three percent and the impact of a stronger euro which accounted for the remaining four percent. Higher selling prices were experienced across the business, while higher volumes were primarily due to pharmaceutical excipients in India and Europe.

Lithium revenue of $53.4 million increased approximately six percent compared to the prior year. Currency impacts for the quarter resulted in a two percent increase in revenue while pricing was up five percent and volumes were down two percent from the prior year. Lithium sales growth was led by higher selling prices in both lithium primaries and specialties. The energy storage market continues to be the highest growth market, supplemented by steady growth in butyl-lithium serving the polymer and pharmaceutical synthesis markets.

Segment operating profit of $47.6 million increased one percent versus the year ago quarter, primarily driven by strong commercial performance discussed above. The strong commercial performance was largely offset by higher raw material and energy costs within the segment and weather-related operating impacts at our Argentina lithium facility. Selling, general and administrative expense increased by 24 percent or $4.1 million to support growth initiatives.

### Industrial Chemicals

*(in Millions)*

| 2011 | Three Months Ended September 30, | 2010 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $264.0 | $262.4 | $1.6 | 1% |
| Operating Profit | 36.0 | 30.0 | 6.0 | 20 |

Revenue in Industrial Chemicals was $264.0 million, an increase of approximately one percent versus the prior-year quarter. The absence of phosphate and sulfur derivatives revenue in the third quarter of 2011 negatively impacted revenues in the segment of approximately 11 percent. The negative impact from the absence of phosphate and sulfur derivative revenue was more than offset by favorable pricing, currency and higher freight billings. Third quarter segment revenue increased due to higher pricing across the segment of seven percent, higher volumes of one percent, favorable currency impacts of two percent and higher freight billings of two percent.

Alkali revenues of $177.5 million were up 14 percent due to higher pricing particularly in the export market and higher volumes. Export demand continues to be robust, especially in Asia and Latin America. In our domestic market, we experienced higher pricing due to constrained supply while volume growth continues to be in line with the demand recovery being experienced in flat glass, detergents and chemicals.

The segment also experienced increased pricing in our Peroxygens division, where quarter revenues increased by nine percent to $75.4 million. The increased pricing was primarily in our hydrogen peroxide and persulfates product lines which was slightly offset by reduced volumes in our sodium percarbonate product line, which we announced the phase-out of during 2011.

Revenues of $11.1 million increased slightly from $9.7 million year over year in Zeolites and Silicates.

Segment operating profit of $36.0 million increased approximately 20 percent versus the year ago quarter primarily as a result of the higher pricing experienced in Alkali and hydrogen peroxide. The exited phosphate and sulfur derivative businesses had a loss of approximately $1.2 million in third quarter 2010. Partially offsetting the favorable pricing were some higher manufacturing costs in the peroxygens business and in our Alkali division associated with the moving of the longwall mining equipment during the quarter. Selling, general and administrative costs increased 12 percent or $1.5 million, mainly for targeted growth initiatives.

### Other Results of Operations

#### Corporate expenses

Corporate expenses of $12.8 million in the third quarter of 2011 decreased $3.1 million from $15.9 million primarily due to consulting expenses associated with our Vision 2015 initiatives which were incurred in the third quarter of 2010. Corporate expenses are included as a component of the line item “Selling, general and administrative expenses” on our condensed consolidated statements of income.

#### Other income (expense), net

Other income (expense), net is comprised primarily of last-in, first-out (“LIFO”) inventory adjustments and certain employee benefits, including incentive compensation. Our business segments account for their inventory utilizing a first-in-first-out ("FIFO") basis of accounting. The LIFO inventory adjustments are not allocated to the business segments and therefore are recorded to "Other income (expense), net". Other expense decreased to $2.9 million in the third quarter of 2011 from $3.5 million in the same period of 2010. The third quarter of 2011 was positively impacted by $2.3 million due to the favorable impact of the mark to market of our deferred compensation liability which represented a charge of $1.2 million in the third quarter of 2010. This reduction in other expense was partially offset by a charge related to an increase in our LIFO inventory reserve of $1.4 million which for the three months ended September 30, 2010 was income of $2.9 million. Other income (expense), net is included as a component of the line item “Costs of sales and services” on our condensed consolidated statements of income.

#### Interest expense, net

Interest expense, net for the third quarter of 2011 was $9.1 million as compared to the third quarter of 2010 of $9.6 million. The decrease was primarily due to the maturity of our 7.8% debenture on July 1, 2011, resulting in a reduction to interest expense of $0.9 million.

#### Corporate special income (charges)

#### Restructuring and other charges (income)

These charges totaled $13.4 million in the third quarter of 2011 compared to $3.7 million in the third quarter of 2010. Please see the table and further discussion regarding our restructuring and other charges (income) in Note 8 to our condensed consolidated financial statements included in this Form 10-Q. Charges (income) in this category for the quarter ended September 30, 2011, include the following:

Restructuring charges and asset impairments:

- A $10.1 million charge related to accelerated depreciation associated with our phase-out of the Sodium Percarbonate plant assets in La Zaida, Spain, which is part of our Industrial Chemicals segment. The plant assets will operate through the fourth quarter of 2011. We will recognize approximately $5 million of additional accelerated depreciation through to the end of 2011.
- A $0.6 million charge related to miscellaneous exit activities associated with our Huelva, Spain facility, which is part of our Industrial Chemicals segment.
- $1.6 million of other net charges primarily related to adjustments to previously recorded restructuring reserves.

Other charges (income), net:

- Corporate net charges of $1.1 million relating to environmental remediation at operating sites.

The restructuring and other charges (income) of $3.7 million recorded in the third quarter of 2010 were a result of the following:

Restructuring charges and asset impairments:

- A $1.0 million charge in our Industrial Chemicals segment due to our decision in 2009 to phase out operations of our Barcelona, Spain facility.
- $0.7 million of other net charges primarily related to adjustments to previously recorded restructuring reserves.

Other charges (income), net:

- Corporate net charges of $1.3 million relating to environmental remediation at operating sites.
- $0.7 million of other miscellaneous net charges.

#### Non-operating pension and postretirement charges

The charge for the three months ended September 30, 2011 was $3.4 million compared to $4.1 million for the three months ended September 30, 2010. These expenses are included as a component of the line item "Selling, general and administrative expenses" on our condensed consolidated statements of income.

#### Provision for income taxes

Provision for income taxes was $29.8 million for the third quarter of 2011 compared to a provision of $32.3 million for the prior year period resulting in effective tax rates of 23.5 percent and 27.3 percent, respectively. The decrease in the effective tax rate was primarily the result of tax benefits recognized for prior year tax matters. Additionally, changes in the mix of domestic income compared to income earned outside of the U.S. also impacted the effective tax rate. Income we earn domestically is typically taxed at rates higher than income earned outside the U.S.

#### Discontinued operations, net of income taxes

Our discontinued operations represent adjustments to retained liabilities primarily related to operations discontinued between 1976 and 2001. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance and long-term obligations related to legal proceedings.

Discontinued operations, net of income taxes totaled a charge of $6.3 million for the three months ended September 30, 2011, compared to a charge of $0.3 million for the three months ended September 30, 2010. The charge for the three months ended September 30, 2011, was primarily related to an increase in our reserves for operating and maintenance activities and charges for legal reserves and expenses related to discontinued operations.

The charge for the three months ended September 30, 2010, was primarily related to an increase in our reserve for operating and maintenance activities and charges for legal reserves and expenses related to discontinued operations, partially offset by income from an adjustment associated with a tax matter related to a previously discontinued operation.

#### Net income attributable to FMC stockholders

Net income attributable to FMC stockholders increased to $86.8 million for the three months ended September 30, 2011, from $82.9 million for the three months ended September 30, 2010. The increase was primarily due to higher operating profits in all three of our segments, decreased corporate expenses and a lower effective tax rate as stated above. These items were partially offset by the increase in restructuring and other charges and discontinued operations.

### Nine months ended September 30, 2011 compared to nine months ended September 30, 2010

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

### Segment Results

### Agricultural Products

*(in Millions)*

| 2011 | Nine Months Ended September 30, | 2010 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $1,055.3 | $907.3 | $148.0 | 16% |
| Operating Profit | 275.7 | 247.5 | 28.2 | 11 |

Revenue of $1,055.3 million increased approximately 16 percent versus the prior year period due to strong sales in North America, Latin America and Asia offset by the expected decline in EMEA. North America revenue of $259.1 million increased 14 percent due to increased volumes as a result of strong market demand for our pre-emergent herbicides partially offset by unfavorable weather conditions experienced in the second quarter of 2011. Latin America revenue of $473.1 million increased 21 percent driven by favorable market conditions, particularly in Brazil's sugarcane, cotton and soybean markets, and growth in planted acres for key crops. Revenue in Asia of $194.4 million increased 30 percent reflecting continued strong market conditions, particularly in Australia, China, Indonesia Thailand, Pakistan and India. As expected, these increases were partially offset by a decline in EMEA revenues of eight percent to $128.7 million. The decline was primarily driven by the absence of sales of our bifenthrin product in Europe which is further discussed below under "Certain Regulatory Issues".

Agricultural Products' operating profit of $275.7 million increased approximately 11 percent compared to prior year, reflecting the strong sales growth partially offset by increased raw material costs and a $21.6 million or 16 percent increase in selling and administrative expenses for focused growth initiatives, higher people-related costs and unfavorable exchange impacts.

In 2011, we expect full-year revenue growth of approximately 15 percent driven by increased volumes, particularly in Latin America, Asia and North America, due to strong market conditions and growth in new and recently introduced products. We expect full-year segment operating profit growth of approximately 10 percent driven by the sales gains partially offset by increased spending on targeted growth initiatives and higher raw material costs.

#### Certain Regulatory Issues

In our Agricultural Products segment, several products are undergoing re-registration in the U.S. and/or a comparable regulatory review by the European Union (“EU”) governmental authorities. In August 2006, the U.S. Environmental Protection Agency (“EPA”) issued its “Interim Reregistration Eligibility Decision” (“IRED”) for our carbofuran insecticide under the U.S. federal pesticide law. The IRED proposed cancellation of all carbofuran uses in the United States, subject to a phase out period for certain minor crop uses, while maintaining tolerances for imported commodities (bananas, coffee, rice and sugarcane). The EPA reiterated its proposal in January 2008, with the issuance of a draft Notice of Intent to cancel carbofuran use (“Notice”). In February 2008, the EPA convened a Scientific Advisory Panel meeting to evaluate scientific issues relevant to the Notice. Separately, the U.S. Department of Agriculture issued its comments on the Notice, stating that carbofuran should continue to be registered. On July 24, 2008, the EPA published a proposal to revoke all carbofuran tolerances under the Federal Food Drug and Cosmetic Act in advance of any issuance of a final Notice under the federal pesticide law. We responded to that notice, expressing our strong disagreement with the EPA's proposal to revoke tolerances and our belief that carbofuran residues on food do not pose a threat to human health. In May 2009, the EPA published its final revocation of all carbofuran tolerances effective December 31, 2009. We filed our objections to this revocation and requested a hearing before an administrative law judge. On October 30, 2009, the EPA denied our objections and our request for a hearing. We believed that we were entitled to a hearing and therefore challenged the EPA's decision by seeking judicial review in the U.S. federal courts. In light of the December 31, 2009, tolerance revocation, we ceased sales of carbofuran in the United States. FMC's sales of our carbofuran products in the United States were not significant and termination of such U.S. sales did not have a material effect on the Company's financial condition or results of operations. On July 23, 2010, the U.S. Court of Appeals for the D.C. Circuit (“the Court of Appeals”) ruled that the EPA acted arbitrarily and capriciously in revoking the import tolerances, and ordered that those tolerances be reinstated. However, the Court did not extend its rationale to the domestic tolerances and instead ruled that the EPA had the right to deny our request for administrative hearing. We subsequently filed a petition for writ of certiorari with the U.S. Supreme Court to overturn the adverse ruling by the Court of Appeals. In May 2011, the U.S. Supreme Court denied our petition, effectively closing our opportunity for potential judicial relief from EPA's tolerance denial. As a result, in June 2011, we voluntarily requested cancellation of all remaining U.S. pesticide registrations for carbofuran formulations; these cancellations have now been finalized.

In the EU, following an administrative appeals process, the European Commission's proposal to exclude our bifenthrin product from the European Commission's official list of approved pesticides, was adopted on November 30, 2009. FMC had an additional six months to sell bifenthrin in the EU (i.e., through end-May 2010), and subsequently, in most EU countries, there is up to 6-12 months for further sale by distributors or dealers, and use by farmers. On December 30, 2010, the French Ministry of Agriculture issued a notice adding bifenthrin, along with eight other pesticidal active ingredients, to the “Grenelle” list of pesticides. While not superseding the remaining sell-out and usage period allowed by the EU decision, the Grenelle listing has had the practical effect of discouraging product use in France during 2011. At the European level, we have re-submitted for reconsideration and the product dossier is now being reviewed by relevant European authorities. At the French level, we believe that the Grenelle listing was unwarranted and contrary to French administrative law, and we are challenging the decision. Through these efforts, we are seeking to minimize the interruption in existing and future bifenthrin sales in the European market. During 2011, however, we are not selling any bifenthrin for agricultural use into the EU and the absence of such sales will not have a material effect on the Company's financial condition or results of operations.

We intend to defend vigorously all our products in the U.S., EU and other countries' regulatory processes where FMC's pesticide products will be reviewed in the ordinary course of regulatory programs during 2011 as part of the ongoing cycle of re-registration in countries around the world. The Brazilian health surveillance agency has informed us that they intend to review carbofuran along with 13 other major pesticides, but has yet to issue any required formal announcement that identifies their specific concerns or preliminary position on re-registration. We are cooperating and defending our product in this process. Under the Brazilian regulatory process, any recommendation would require public notice and comment as well as concurrence from the Brazilian environmental and agricultural ministries before any regulatory change is effective. Thus, we do not expect a sales impact in Brazil in 2011.

### Specialty Chemicals

*(in Millions)*

| 2011 | Nine Months Ended September 30, | 2010 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $656.5 | $619.4 | $37.1 | 6% |
| Operating Profit | 148.5 | 139.0 | 9.5 | 7 |

Revenue in Specialty Chemicals was $656.5 million, an increase of approximately six percent versus the prior year. The increase was driven primarily by volume increases and higher pricing in BioPolymer and favorable pricing in lithium specialties and favorable currency impacts.

BioPolymer revenue of $494.2 million increased approximately seven percent from the prior year. This increase was due to higher volumes which increased revenue by three percent, favorable pricing which impacted sales by two percent and the impact of a stronger euro which accounted for the remaining two percent. The volume gains and higher pricing were realized in both the food ingredients and pharmaceutical markets.

Lithium revenue of $162.3 million increased approximately three percent compared to the prior year. Currency impacts resulted in a two percent increase in revenue while pricing was up three percent and volumes were down three percent from the prior year. Lithium has been impacted by tightening of supply.

Segment operating profit of $148.5 million increased seven percent versus the prior year. The increase was primarily driven by the volume gains, higher pricing and favorable mix in BioPolymer and favorable pricing in Lithium offset by lower volumes due to adverse weather conditions in Argentina which impacted mining operations. Selling, general and administrative expenses increased by 16 percent or $8.4 million to support growth initiatives.

In 2011, we expect full-year revenue growth in the mid-single digits, driven by higher volumes and selling prices in BioPolymer and lithium specialties. Full-year segment operating profit growth is expected in the high-single digits, driven by higher sales, partially offset by increased spending on growth initiatives and higher raw material costs.

As we anticipate ongoing growth for microcrystalline cellulose ("MCC") on a global basis, especially high in rapidly developing economies, in March 2011 we completed the expansion of our MCC plant in Cork, Ireland. The expansion, now in full production, increased our global capacity by approximately 25 percent for food and pharmaceutical grade MCC.

### Industrial Chemicals

*(in Millions)*

| 2011 | Nine Months Ended September 30, | 2010 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $761.3 | $781.7 | $(20.4) | (3)% |
| Operating Profit | 112.5 | 94.3 | 18.2 | 19 |

Revenue in Industrial Chemicals was $761.3 million, a decrease of approximately three percent versus the prior year. The decrease is primarily attributable to the exit of our phosphate and sulfur derivative businesses in Spain during 2010. The absence of phosphate and sulfur derivatives revenue in 2011 resulted in overall revenue declines in the segment of approximately 12 percent. The decline in these revenues were partially offset by higher pricing across the segment, particularly in soda ash, which impacted revenues by approximately six percent. Higher freight billing and favorable currency impacts increased revenue by approximately three percent.

Alkali revenues of $505.9 million increased nine percent over the prior year due to higher pricing particularly in the export market and higher freight billings. Export demand continues to be robust, especially in Asia and Latin America. In our domestic market, we experienced higher pricing due to constrained supply while volume growth continues to be in line with the demand recovery being experienced in flat glass, detergents and chemicals.

Peroxygens revenues of $220.2 million increased 11 percent over the prior year driven primarily by higher pricing and slightly favorable currency impacts offset slightly by slightly reduced volumes. The increased pricing was primarily in our hydrogen peroxide and specialty persulfates product lines.

Revenues of $35.2 million were 17 percent higher year over year in Zeolites and Silicates from $30.1 million in the prior year.

Segment operating profit of $112.5 million increased approximately 19 percent versus the year ago period primarily as a result of the higher pricing documented above. The exited phosphate and sulfur derivative businesses added $0.7 million of segment operating earnings in the nine months ended September 30, 2010. Additionally, the startup costs associated with our Granger soda ash facility were offset by favorable production efficiencies in Alkali. Selling, general and administrative costs increased 11 percent or $4.1 million primarily for targeted growth initiatives.

In 2011, we expect full-year revenue to be approximately level as higher selling prices in soda ash and peroxygens and volume growth in soda ash export markets will be offset by the absence of revenue from the exited phosphate and sulfur derivative businesses. We expect full-year operating profit growth of approximately 25-30 percent, driven by higher sales gains in soda ash and peroxygens and the continued mix shift toward specialty peroxygens.

Recent events in Venezuela, such as hyperinflation, devaluation of currency, government price controls, parallel exchange rates, and political issues have created significant risks and uncertainties for the Venezuelan subsidiaries of multinational corporations. We hold a noncontrolling investment in a Venezuelan phosphate business, Tripoliven C.A. The value of this investment on our condensed consolidated balance sheet at September 30, 2011 is approximately $9 million. While there has been a lag between the declaration and payment to us of dividends from Tripoliven, we did receive dividends from Tripoliven during 2010. We do not believe there is any impairment of Tripoliven at September 30, 2011, as Tripoliven continues to operate as a profitable business and we expect in the future to recover at least the value of our investment. If our investment in Tripoliven were to be totally impaired, it would have an immaterial impact on our liquidity or consolidated financial position, but the impairment charge would have a one-time effect on our results of operations in the period in which it would be recorded.

### Other Results of Operations

#### Corporate expenses

We recorded expenses of $45.2 million in the nine months ended September 30, 2011 compared to $42.9 million in the same period 2010. The increase was primarily due to increased incentive compensation of approximately $0.5 million and consulting expenses of approximately $1.0 million incurred during 2011 compared to the same period in 2010. The increase in consulting expenses is a result of the initiatives which began in the latter part of 2010, primarily involving global procurement, aimed at reducing the costs of goods and services purchased on a world-wide basis. Corporate expenses are included as a component of the line item “Selling, general and administrative expenses” on our condensed consolidated statements of income.

#### Other income (expense), net

Other expense increased to $15.1 million in the nine months ended September 30, 2011 from $5.6 million in the same period of 2010. The increase was primarily due to expense related to an increase in our LIFO inventory reserves in 2011 of $4.1 million versus 2010 where we had income of $8.7 million, resulting in a period-to-period change of $12.8 million. Additionally, the first nine months of 2010 was positively impacted by $1.5 million due to the favorable impact from the mark to market of our deferred compensation liability which did not recur in the same period of 2011. Other income (expense), net is included as a component of the line item “Costs of sales and services” on our condensed consolidated statements of income.

#### Interest expense, net

Interest expense, net for the nine months ended September 30, 2011 of $29.5 million was relatively flat compared to the same period in 2010 of $29.0 million.

#### Corporate special income (charges)

#### Restructuring and other charges (income)

These charges totaled $27.2 million in the nine months ended September 30, 2011 compared to $35.7 million in for the same period in 2010. Charges (income) in this category for the nine months ended September 30, 2011, include the following:

Restructuring charges and asset impairments:

- A $15.6 million charge related to severance and employee benefits and accelerated depreciation associated with our phase-out of the Sodium Percarbonate plant assets in La Zaida, Spain, which is part of our Industrial Chemicals segment.
- A $1.4 million charge related to additional miscellaneous disposal costs associated with our Alginates manufacturing operations in our Specialty Chemicals segment.
- A $2.1 million charge primarily related to miscellaneous exit activities associated with our Huelva, Spain facility, which is part of our Industrial Chemicals segment.
- A $0.4 million charge from additional miscellaneous exit and disposal costs related to our Santa Clara, Mexico facility, which is part of our Industrial Chemicals segment.
- $2.0 million of severance charges related to our Specialty Chemicals ($0.7 million) and Industrial Chemicals ($1.2 million) segments and Corporate ($0.1 million).

Other charges (income), net:

- Corporate net charges of $4.2 million primarily relating to environmental remediation at operating sites.
- $1.5 million of net miscellaneous charges in our Agricultural Products ($1.2 million) and Industrial Chemicals ($0.3 million) segments.

The restructuring and other charges (income) of $35.7 million recorded in the nine months ended September 30, 2010 were a result of the following:

Restructuring charges and asset impairments:

- A $6.1 million charge in our Specialty Chemicals segment due to the continued realignment of our BioPolymer alginates manufacturing operations. The charge primarily consisted of the accrual of costs associated with leased properties which we have ceased using.
- In 2009, we made the decision to close our Bayport butyllithium facility located in Bayport, Texas, which is part of our Specialty Chemicals segment. We recorded $1.1 million of income which primarily consisted of a reduction of previously recorded retirement obligations at the site of $0.9 million.
- A $10.6 million charge in our Industrial Chemicals segment due to our decision in 2009 to phase out operations of our Barcelona, Spain facility. The charge primarily consisted of accelerated depreciation on fixed assets to be abandoned of $10.1 million.
- In 2009, we made the decision to shut down our manufacturing operations at our Peroxygens facility in Santa Clara, Mexico, which is part of our Industrial Chemicals segment. In the second quarter of 2010, we recorded $1.1 million of income which related to the reversal of a previously recorded loss contingency.
- Severance costs due to other workforce restructurings of $2.3 million primarily related to our

Industrial Chemicals segment.

- A $0.7 million gain primarily related to foreign currency translation adjustment as a result of the liquidation of a legal entity that owned a co-generation facility in Spain.

Other charges (income), net:

- Corporate net charges of $9.7 million relating to environmental remediation at operating sites.
- A $5.7 million charge related to our Agricultural Products segment acquiring certain rights relating to a herbicide compound still under development.
- $1.5 million of net charges primarily related to a legal settlement associated with the U.S. hydrogen peroxide matter in our Industrial Chemicals segment.
- $2.7 million of charges primarily relating to the accrual of interest associated with a European Commission fine and adjustments related to previously recorded restructuring reserves.

#### Non-operating pension and postretirement charges

The charge for the nine months ended September 30, 2011 was $12.4 million compared to $9.7 million for the nine months ended September 30, 2010. The increase in charges is a result of amortization related to pension asset losses incurred in prior periods and a decrease in actual plan discount rates in both 2010 and 2009.

#### Provision for income taxes

Provision for income taxes was $96.1 million for the nine months ended September 30, 2011 compared to a provision of $106.8 million for the prior year period resulting in effective tax rates of 22.9 percent and 29.1 percent, respectively. The decrease in the effective tax rate is consistent with the change in the three months ended September 30, 2011, and the $14.1 million tax adjustment to reverse the uncertain tax liability as a result of the settlement of audits. The change was also impacted by a tax adjustment of $3.5 million recorded during the nine months ended September 30, 2010, that did not repeat in 2011. This was due to a charge associated with a change in the tax treatment of the Medicare Part D subsidy which was enacted as part of the recent U.S. health care reform legislation. Additionally, changes in the mix of domestic income compared to income earned outside of the U.S. also impacted the effective tax rate. Income we earn domestically is typically taxed at rates higher than income earned outside the U.S.

#### Discontinued operations, net of income taxes

Discontinued operations, net of income taxes totaled a charge of $23.2 million for the nine months ended September 30, 2011, compared to a charge of $25.3 million for the nine months ended September 30, 2010. The charges for the nine months ended September 30, 2011, were primarily related to an increase in our reserves associated with our Front Royal site, operating and maintenance activities and charges for legal reserves and expenses related to discontinued operations.

The charges for the nine months ended September 30, 2010, were primarily related to an increase in the provision for environmental issues at our Middleport site as well as operating and maintenance activities and charges for legal reserves and expenses related to discontinued operations.

#### Net income attributable to FMC stockholders

Net income attributable to FMC stockholders increased to $288.0 million for the nine months ended September 30, 2011, from $226.0 million for the nine months ended September 30, 2010. The increase was primarily due to higher operating profits in all three of our segments, a lower effective tax rate due to the reversal of uncertain tax contingencies and lower restructuring and other charges (income). These items were partially offset by the increase in corporate expenses, non-operating pension and postretirement charges and LIFO inventory adjustments.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at September 30, 2011 and December 31, 2010, were $109.4 million and $161.5 million, respectively. Of the cash and cash equivalents balance at September 30, 2011, $73.7 million were held by our foreign subsidiaries. Our intent is to reinvest permanently the earnings of our foreign subsidiaries and therefore we have not recorded taxes that would be payable if we repatriated these earnings. In the event that funds from our foreign subsidiaries are repatriated to the U.S., we would be required to accrue and pay U.S. taxes on those amounts.

At September 30, 2011, we had total debt of $571.1 million as compared to $637.9 million at December 31, 2010. This included $493.6 million and $503.0 million of long-term debt (excluding current portions of $47.4 million and $116.4 million) at September 30, 2011 and December 31, 2010, respectively. Short-term debt, which consists solely of foreign borrowings, increased to $30.1 million at September 30, 2011, compared to $18.5 million at December 31, 2010.

#### 2011 Credit Agreement

On August 5, 2011 we executed a new revolving credit facility, referred to as the 2011 Credit Agreement. The 2011 Credit Agreement provides for a $1.5 billion unsecured revolving credit facility ($300 million of which is available for the issuance of letters of credit for the account of the Company and certain foreign subsidiaries ("Borrowers") and $50 million of which is available for swing line loans to certain Borrowers) with an expansion feature, subject to certain conditions, to increase the facility to $2.25 billion.

There were no borrowings under the 2011 Credit Agreement at inception, and our prior domestic and European credit agreements dated as of August 28, 2007 and February 21, 2008, respectively, were terminated at that time. Obligations under the prior credit agreements and related transaction costs, fees, and expenses for the 2011 Credit Agreement were paid with available cash.

Loans under the 2011 credit agreement will bear interest at either a floating rate, which will be a base rate, or a Eurocurrency rate equal to the London Inter-Bank Offered Rate for the relevant term, plus in each case an applicable margin. The applicable margin is 1.13 percent per year, subject to adjustment based on the credit rating assigned to our senior unsecured debt. We are required to pay a facility fee on the total amount of the credit facility. The initial facility fee is 0.15 percent per year. The applicable margin and the facility fee are subject to adjustment based on the rating assigned to our long-term senior unsecured debt.

Among other restrictions, the 2011 Credit Agreement contains financial covenants applicable to FMC and its consolidated subsidiaries related to leverage (measured as the ratio of debt to adjusted earnings) and interest coverage (measured as the ratio of adjusted earnings to interest expense). Our actual leverage for the four consecutive quarters ended September 30, 2011, was 1.0 which is below the maximum leverage of 3.5. Our actual interest coverage for the four consecutive quarters ended September 30, 2011, was 14.8 which is above the minimum interest coverage of 3.5. We were in compliance with all covenants at September 30, 2011.

#### Statement of Cash Flows

*Cash provided by operating activities was $327.8 million for the nine months ended September 30, 2011.*

Income from continuing operations of $323.7 million included net charges of $21.5 million, of which $10.1 million was for non-cash asset write-downs related to the exit of various facilities and $11.4 million of other facilities exit costs to be settled in cash, mainly for severance costs and lease obligations. Cash spending on restructuring and other charges in the nine months ended September 31, 2011 was $79.4 million and included the payment associated with European Union Fine of $43.8 million(further discussed in Note 18 to the condensed consolidated financial statements this Form 10-Q). The remaining restructuring and other charges payments are primarily related to the Huelva facility shutdown. Also included in income from continuing operations was $4.1 million for environmental and remediation at our operating sites, which will be spent in years beyond 2011. Net cash spending on environmental remediation at our operating sites in the nine months ended September 30, 2011 was $7.0 million which was recorded against pre-existing reserves. Income from continuing operations is also adjusted for other non-cash items which include share-based compensation expense and excess tax benefits from share-based compensation.

Accrued customer rebates was an addition to cash of $97.1 million due to increased sales primarily in our Agricultural Products segment. These rebates are primarily in North America and Brazil and generally settle in the fourth quarter of each year. The customer rebate cash addition was more than offset by a cash outflow of $94.2 million to increase our inventory balance driven by projected demand in Agricultural Products and accounts payable, which decreased $45.3 million due primarily to liquidation of vendor payables associated with our exited phosphate business in 2011.

Accrued pension and other postretirement benefits were a use of cash of $55.2 million which included a voluntary contribution to our U.S. defined benefit plan of $48.0 million.

*Cash provided by operating activities was $308.2 million for the first nine months of 2010.*

Income from continuing operations of $260.5 million included net charges of $16.1 million, of which $9.9 million was for non-cash asset write-downs related to the exit of various facilities announced in 2009 and $6.2 million of other facilities exit costs to be settled in cash, mainly for severance costs and lease obligations. Cash spending on restructuring and other charges in the first nine months of 2010 was $47.4 million. Also included in income from continuing operations was $9.7 million for environmental and remediation at our operating sites, which will be spent in years beyond 2010. Net cash spending on environmental remediation at our operating sites in the first nine months of 2010 was $6.3 million which was recorded against pre-existing reserves. Income from continuing operations is also adjusted for other non-cash items which include stock-based compensation expense and excess tax benefits from share-based compensation. There was a significant increase in excess tax benefits from share-based compensation because we utilized our remaining U.S. financial net operating losses in 2010.

Receivables were a use of cash of $68.4 million due to revenue increases in our businesses, particularly for Agricultural Products sales in Brazil where terms are significantly longer than in the rest of our businesses. Partially offsetting the higher receivables were accrued customer rebates which increased by $97.7 million due to increased sales primarily in our Agricultural Products segment. These rebates are primarily in North America and Brazil and generally settle in the fourth quarter of each year. Accounts payables also increased as a result of a higher focus on payables management.

Accrued pension and other post retirement benefits were a use of cash of $86.3 million which included a voluntary contribution to our U.S. defined benefit plan of $80 million.

*Cash required by operating activities of discontinued operations was $29.8 million and $23.4 million for the nine months ended September 30, 2011 and 2010, respectively.*

This change was primarily due to increased net environmental spending in the nine months ended September 30, 2011, compared to the prior year period.

*Cash required by investing activities was $136.9 million and $107.3 million for the nine ended September 30, 2011 and 2010, respectively.*

The increase in spending during the nine months ended September 30, 2011, as compared to the same period in 2010 was primarily due to increased capital expenditures associated with capacity expansions.

*Cash required by financing activities was $214.0 million as compared to an addition of cash of $13.3 million for the nine months ended September 30, 2011 and 2010, respectively.*

This increase is primarily due to higher repurchases of common stock, higher repayments on our long-term debt, as well as a decrease in excess tax benefits associated with share based compensation partially offset by an increase in our short-term debt borrowings.

### Other potential liquidity needs

Our cash needs for 2011 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, contributions to our pension plans, environmental spending, restructuring, pending acquisitions and legal settlements. We plan to meet our liquidity needs through available cash; cash generated from operations and borrowings under our committed revolving credit facilities. We continually evaluate our options for divesting real estate holdings and property, plant and equipment that are no longer integral to any of our core operating businesses.

Projected 2011 capital expenditures are expected to be approximately 30 percent higher than 2010 levels, primarily to increase capacity in BioPolymer, Lithium and Alkali.

Projected 2011 spending includes approximately $30 million of net environmental remediation spending. This spending does not include expected spending of approximately $7 million in 2011 on capital projects relating to environmental control facilities. Also, we expect to spend approximately $24 million in 2011 for environmental compliance costs, which we will include as a component of costs of sales and services in our condensed consolidated statements of income since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls above the foregoing projections.

In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan, we have made voluntary contributions through September 30, 2011 of $48.0 million and intend to contribute a total of approximately $55.0 million in

2011\. These contributions are in excess of the minimum requirements. We made voluntary contributions of $80.0 million in 2010. We do not believe that any additional contributions will have a significant negative impact on our current and future liquidity needs. However, a continuation of the volatility of interest rates and negative equity returns under current market conditions may require greater contributions to the U.S. Plan in the future.

On October 20, 2011, we paid dividends totaling $10.6 million to our shareholders of record as of September 30, 2011. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheets as of September 30, 2011.

On October 24, 2008, the Board of Directors authorized the repurchase of up to $250.0 million of our common stock. At December 31, 2010, $54.8 million remained unused of the 2008 authorization. On February 18, 2011, the Board authorized the repurchase of up to an additional $250.0 million of our common stock for a total of $304.8 million. The repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. During the three and nine months ended September 30, 2011, 1,274,900 and 1,393,478 shares, respectively, were repurchased under the publicly announced repurchase program for $100 million and $110 million, respectively. From time to time we acquire shares from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.

On July 21, 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the "Dodd-Frank Act") was signed into law. Title VII of the Act contains significant changes in the ways derivatives are regulated. Several U.S. government regulatory agencies and departments are charged with developing the many regulations required under the new law. While the exact effects on FMC cannot be known until final regulations are promulgated, we believe they will not adversely affect our liquidity in a material way.

### Commitments and Contingencies

See Note 18 to our condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our commitments and contingencies. As discussed in Note 18, a motion for summary judgment was decided in our favor on March 29, 2011 for the Lewis et al v. FMC Corporation lawsuit. On April 28, 2011, the plaintiffs in the case filed an appeal of that decision to the U.S. Court of Appeals for the Second Circuit, but failed to perfect the appeal, and the case was dismissed. The plaintiffs filed a new complaint in New York state court in late September 2011 on the state law claims on which the federal district judge did not rule in granting the summary judgment motion in the original lawsuit. In October 2011, we removed the new lawsuit from the state court to federal court based on diversity of citizenship and filed a motion to dismiss the case on the basis of improper and untimely service of process.

Additionally, as also discussed in Note 18, we and our wholly-owned Spanish subsidiary Foret appealed the decision of the European Commission to fine us in connection with alleged violations of competition laws, and on June 16, 2011, the General Court affirmed the judgment of the Commission as to us and Foret. On August 11, 2011, Foret paid the fine of €25.0 million (U.S. $36.3 million) and we paid €5.1 million (U.S. $7.5 million) in accrued interest.

### Climate Change

A detailed discussion on climate change can be found in Part II, Item 7 of our 2010 Form 10-K. We expect the total greenhouse gas emissions from our Green River, Wyoming operations to increase in 2011 as we re-commission the first phase of natural soda ash capacity at our Green River facility known as Granger. Our carbon emissions intensity is expected to remain favorable in comparison with our synthetic soda ash competition. We have announced engineering of a second phase expansion at the Granger facility involving solution mining. Although this expansion will reduce our energy and carbon intensity, if approved by the Board of Directors, the second-phase expansion project may require a review for greenhouse gas emissions by the U.S. EPA. Such a review could impact project schedule or cost.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### Fair-Value Measurements

See Note 17 to our condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At September 30, 2011, our net financial instrument position was a net liability of $2.4 million compared to a net liability of $6.8 million at December 31, 2010. The change in the net financial instrument position was primarily due to lower unrealized losses in our commodity and foreign exchange portfolios.

### Commodity Price Risk

Energy costs are approximately nine percent of our cost of sales and services and are diversified among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at September 30, 2011 and December 31, 2010, with all other variables (including interest rates) held constant. A 10 percent increase in energy market prices would result in a decrease in the net liability position of $3.0 million at September 30, 2011, compared to a $3.4 million decrease of the net liability position at December 31, 2010. A 10 percent decrease in energy market prices would result in an increase of $3.0 million in the net liability position at September 30, 2011, compared to an increase of $3.4 million of the net liability position at December 31, 2010.

Our Agricultural Products segment enters into contracts with certain customers in Brazil to exchange our products for future physical delivery of soybeans. To mitigate the price risk associated with these barter contracts, we enter into offsetting derivatives to hedge our exposure. As of September 30, 2011 our net financial instrument position was immaterial. As of December 31, 2010, we had no such contracts in place.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan and the U.S. dollar versus the Brazilian real. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at September 30, 2011 and December 31, 2010, with all other variables (including interest rates) held constant. A 10 percent strengthening of hedged currencies versus our functional currencies would have resulted in a decrease of $5.0 million in the net asset position at September 30, 2011, compared to an increase of $33.3 million in the net liability position at December 31, 2010. As a result, at September 30, 2011, the net asset position would have become a net liability position. A 10 percent weakening of hedged currencies versus our functional currencies would have resulted in an increase of $4.8 million in the net asset position at September 30, 2011, compared to a decrease of $31.1 million in the net liability position at December 31, 2010. As a result, at December 31, 2010, the net liability position would have become a net asset position.

### Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of September 30, 2011 and December 31, 2010, we had no interest rate swap agreements.

Our debt portfolio, at September 30, 2011, is composed of 87 percent fixed-rate debt and 13 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our 2011 credit agreement, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate debt in our debt portfolio at September 30, 2011, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $0.4 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $0.2 million for the nine months ended September 30, 2011.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 3,488 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended September 30, 2011, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of September 30, 2011, the related condensed consolidated statements of income for the three-month and nine-month periods ended September 30, 2011 and 2010, and the related condensed consolidated statements of cash flows for the nine-month periods ended September 30, 2011 and 2010. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2010, and the related consolidated statements of income, changes in equity, cash flows and comprehensive income for the year then ended (not presented herein); and in our report dated February 22, 2011, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2010, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

### /s/ KPMG LLP

Philadelphia, Pennsylvania

November 2, 2011

Filed Nov 2, 2011.
Source: SEC EDGAR, the filing index for accession 0000037785-11-000033. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
